The United Nations High Level Panel on Access to Medicines released its report this week advising that like poor countries, middle-income countries should not have to pay licensing fees to pharmaceutical companies. However, it ignores several key points. Cost of Free IP The United Nations High Level Panel on Access to Medicines released its report this week advising that like poor countries, middle-income countries should not have to pay licensing fees to pharmaceutical companies. Since 95 percent of medicines on the WHO’s essential drugs list are off-patent, this recommendation would mostly make newer, cutting-edge drugs free to use. In essence, the report concludes that intellectual property (IP) rights are inconsistent with public heal...
What You Need to Know Today: Russia rejected calls for a ceasefire in the Black Sea, including a proposal to halt attacks on civilian shipping that could help restore grain flows from Ukrainian ports. Tyson Foods announced plans to permanently close its Joslin, Illinois, beef processing facili...
What You Need to Know Today: Wholesale inflation was flat in July, with the Producer Price Index (PPI) unchanged versus expectations for a 0.2 percent increase. Core PPI rose 0.2 percent, also below expectations. The softer inflation data has reduced the odds of a September interest rate incre...
From WPI Consulting
Infrastructure investment due diligence
On behalf of a Canadian oilseed processer WPI's team provided market analysis, econometric modeling and financial due diligence in support of a $24 million-dollar investment in a Ukrainian crush plant. Consistent with WPI's findings, local production to supply the plant and the facility's output have expanded exponentially since the investment. WPI has conducted parallel work on behalf of U.S., South American and European clients, both private and public, in the agri-food space.